Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review

Clinical Therapeutics

Volumn 30, Issue 11, 2008, Pages 2069-2074

  Iaccheri, Barbara ^a   Fiore, Tito ^a   Papadaki, Thekla ^a   Androudi, Sofia ^a   Janjua, Sarosh ^a   Bhaila, Imran ^a   Stephen Foster, C ^a  

^a Massachusetts Eye Research and Surgery Institute   (United States)

Author keywords

antitoxoplasmic drugs; ocular toxoplasmosis; pyrimethamine; toxoplasma chorioretinitis

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; COTRIMOXAZOLE; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHORIORETINITIS; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; FACE EDEMA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; IRRITABLE COLON; LEUKOPENIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; STOMACH DISCOMFORT; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ATOVAQUONE; CLINDAMYCIN; DRUG COMBINATIONS; DRUG TOXICITY; EXANTHEMA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PYRIMETHAMINE; RETROSPECTIVE STUDIES; SULFADIAZINE; SULFAMETHOXAZOLE; TOXOPLASMOSIS, OCULAR; TRIMETHOPRIM; VITREOUS BODY; YOUNG ADULT;

EID: 57649180021     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.10.021     Document Type: Article

References (15)

1. Dodds E.M. Toxoplasmosis. Curr Opin Ophthalmol 17 (2006) 557-561
2. Rothova A., Meenken C., Buitenhuis H.J., et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol 115 (1993) 517-523
3. Bosch-Driessen L.H., Verbraak F.D., Suttorp-Schulten M.S., et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol 134 (2002) 34-40
4. Hughes W.T., LaFon S.W., Scott J.D., and Masur H. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J Infect Dis 171 (1995) 1295-1301
5. Nussenblatt R.B., Palestine A.G., Chan C.C., and Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92 (1985) 467-471
6. Kaufman H.E., and Geisler P.H. The hematologic toxicity of pyrimethamine (daraprim) in man. Arch Ophthalmol 64 (1960) 140-146
7. Giles C.L. The treatment of toxoplasma uveitis. Am J Ophthalmol 58 (1964) 611-616
8. Mazur N., Greenberger P.A., and Regalado J. Clindamycin hypersensitivity appears to be rare. Ann Allergy Asthma Immunol 82 (1999) 443-445
9. Neu H.C., Prince A., Neu C.O., and Garvey G.J. Incidence of diarrhea and colitis associated with clindamycin therapy. J Infect Dis 135 Suppl (1977) S120-S125
10. Sande M.A., and Mandell G.L. Antibicromial agents: Clindamycin. In: Goodman A.G., Gilman A., Rall T.W., et al. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed (1990), Pergamon Press, New York, NY 1135-1137
11. Bergogne-Bérézin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 16 (2000) 521-526
12. Shear N.H., Spielberg S.P., Grant D.M., et al. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 105 (1986) 179-184
13. Smith J.M., Curi A.L., and Pavesio C.E. Crystalluria with sulphadiazine. Br J Ophthalmol 85 (2001) 1265
14. Foulon W., Villena I., Stray-Pedersen B., et al. Treatment of toxoplasmosis during pregnancy: A multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180 (1999) 410-415
15. Pearson P.A., Piracha A.R., Sen H.A., and Jaffe G.J. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 106 (1999) 148-153